DKCM
KITE

Davidson Kempner Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

Davidson Kempner Capital Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-147,334
Closed -$26.5M – 222
2017
Q3 		$26.5M Buy
+147,334
New +$20.5M 0.35% 47

Davidson Kempner Capital Management's KITE Position: Q4 2017 in Review

Davidson Kempner Capital Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 147,334 shares — an estimated $26.5M sold.

Davidson Kempner Capital Management first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $26.5M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Davidson Kempner Capital Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 147,334 Kite Pharma, Inc. shares in Q4 2017, an estimated $26.5M.
  • Davidson Kempner Capital Management first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Davidson Kempner Capital Management's Kite Pharma, Inc. position peaked at $26.5M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Davidson Kempner Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.